What Drugs Made In America Acquisition II Corp.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 0 | 0 |
| Total trades | 0 | 0 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 0 |
| Disposed | 0 | 0 |
| Net activity | +0 | +0 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Drugs Made In America Acquisition Ii Llc | 10% owner | Sep 26 | Open-market sale · S | −7,966,667 | — | — | 6,708,333 |
| Drugs Made In America Acquisition Ii Llc | 10% owner | Sep 26 | Other Transaction · J | −400,000 | — | — | 14,675,000 |
| Drugs Made In America Acquisition Ii Llc | 10% owner | Sep 26 | Open-market buy · P | +700,000 | — | — | 15,075,000 |
| Stockwell Lynn | CEO and Exe. Chair of Board | Sep 26 | Open-market sale · S | −7,966,667 | — | — | 6,708,333 |
| Stockwell Lynn | CEO and Exe. Chair of Board | Sep 26 | Other Transaction · J | −400,000 | — | — | 14,675,000 |
| Stockwell Lynn | CEO and Exe. Chair of Board | Sep 26 | Open-market buy · P | +700,000 | — | — | 15,075,000 |
| Worman Glenn C. | CFO | Sep 26 | Other Transaction · J | +100,000 | — | — | 100,000 |
| Prasad Sridhar G. | Director | Sep 26 | Other Transaction · J | +100,000 | — | — | 100,000 |
| Shulgan Myron W. | Director | Sep 26 | Other Transaction · J | +100,000 | — | — | 100,000 |
| Do Catherine | Director | Sep 26 | Other Transaction · J | +100,000 | — | — | 100,000 |
Loading...
